Innopharmax (ROCO:4172) YoY EBITDA Growth : -30.38% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Innopharmax YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Innopharmax's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -30.38%.

Innopharmax's EBITDA per Share for the six months ended in Dec. 2024 was NT$-0.52.

Innopharmax YoY EBITDA Growth Historical Data

The historical data trend for Innopharmax's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innopharmax YoY EBITDA Growth Chart

Innopharmax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

63.71

-153.23

-14.97

36.57

-34.64

Innopharmax Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															-9.42	42.54	32.01	-41.18	-30.38

Innopharmax YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Innopharmax's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.925	-	-0.687)	/	\| -0.687 \|
=	-34.64 %

Innopharmax's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-0.515	-	-0.395)	/	\| -0.395 \|
=	-30.38 %

Innopharmax YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Innopharmax's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Innopharmax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innopharmax Inc (ROCO:4172) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 22, Lane 478, Ruiguang Road, 9th Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.innopharmax.com

Innopharmax Inc is a Taiwan based specialty pharmaceutical company. It is focused on the development and commercialization of products for the treatment of oncology and specialty. The company's products include anti-infection agents, contrast agents, oncology agents, immunological agents, drugs for rare diseases and others.

Innopharmax Headlines

No Headlines